Docoh
Loading...

MRNS Marinus Pharmaceuticals

361 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
MRNS Marinus Pharmaceuticals Inc
9 Nov 21
Quarterly report
4:01pm
8-K
MRNS Marinus Pharmaceuticals Inc
9 Nov 21
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
7:03am
8-K
MRNS Marinus Pharmaceuticals Inc
27 Sep 21
Marinus Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
8:00pm
SC 13G
Suvretta Capital Management, LLC
20 Aug 21
MARINUS PHARMACEUTICALS / SUVRETTA CAPITAL MANAGEMENT ownership change
4:36pm
8-K
MRNS Marinus Pharmaceuticals Inc
17 Aug 21
Other Events
4:13pm
8-K
MRNS Marinus Pharmaceuticals Inc
17 Aug 21
Secondary endpoint of 50% responder rate at 30.4%, consistent with the Marigold Phase 3 CDKL5 deficiency disorder trial results
4:09pm
S-8
MRNS Marinus Pharmaceuticals Inc
10 Aug 21
Registration of securities for employees
4:42pm
10-Q
2021 Q2
MRNS Marinus Pharmaceuticals Inc
10 Aug 21
Quarterly report
4:02pm
8-K
MRNS Marinus Pharmaceuticals Inc
10 Aug 21
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
7:16am
8-K
MRNS Marinus Pharmaceuticals Inc
3 Aug 21
Marinus Pharmaceuticals Announces Exclusive Collaboration with Orion Corporation for European Commercialization of Ganaxolone
7:15am
4
MRNS Marinus Pharmaceuticals Inc
2 Jul 21
MARINUS PHARMACEUTICALS / Santiago Arroyo ownership change
6:01am
3
Arroyo Santiago
1 Jul 21
MARINUS PHARMACEUTICALS / Santiago Arroyo ownership change
6:14pm
8-K
MRNS Marinus Pharmaceuticals Inc
1 Jul 21
Marinus Pharmaceuticals Further Strengthens Board of Directors with Appointment of Santiago
5:31pm
8-K
MRNS Marinus Pharmaceuticals Inc
17 Jun 21
Departure of Directors or Certain Officers
4:06pm
8-K
MRNS Marinus Pharmaceuticals Inc
27 May 21
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
MRNS Marinus Pharmaceuticals Inc
16 May 21
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
8:00pm
10-Q
2021 Q1
MRNS Marinus Pharmaceuticals Inc
16 May 21
Quarterly report
8:00pm
DEFA14A
MRNS Marinus Pharmaceuticals Inc
14 Apr 21
Additional proxy soliciting materials
8:00pm
DEF 14A
MRNS Marinus Pharmaceuticals Inc
14 Apr 21
Definitive proxy
5:07pm
4
Steven Pfanstiel
13 Apr 21
MARINUS PHARMACEUTICALS / Steven Pfanstiel ownership change
9:59pm